A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.

Search Database
Name Category Primary Site Code?
131I-MIBG Radiation See Remarks
5-Aza-2'Deoxy-cytidine Chemotherapy CML Yes
5-FP Chemotherapy Breast, gastric, head & neck, liver cancer Yes
ABT 888 Chemotherapy Ovary Yes
ADXS-HPV Biologic therapy (BRM, immunotherapy) Cervix See Remarks
AMG 531 Ancillary Agent No
ATRA-IV Differentiation inducing agent Lymphoma, Acute promyelocytic leukemia Yes
Abecma Biologic therapy (BRM, immunotherapy) Yes
Abemaciclib Chemotherapy Breast Yes
Abiraterone acetate Hormones and hormonal mechanisms Prostate Yes
Abraxane Chemotherapy Metastatic breast cancer, NSCLC, Non small cell lung cancer, cervix, melanoma, pancreas Yes
Acalabrutinib Chemotherapy Yes
Accutane Differentiation inducing agent Prostate cancer No
Acetaminophen Ancillary Agent No
Acetazolamide Ancillary Agent No
Acetylcysteine Ancillary Agent AIDS, Opportunistic infection No
Acitretin Differentiation inducing agent No
Acyclovir Ancillary Agent No
Acyclovir Sodium AIDS drug No
Ad5CMV-p53 (adenovirus p53) Biologic therapy (BRM, immunotherapy) Glioma, Head & neck, lung cancer No
Ado-trastuzumab emtansine Biologic therapy (BRM, immunotherapy) Metastatic HER-2 breast cancer Yes
Adrenocorticotropic hormone Hormones and hormonal mechanisms See Remarks
Adstiladrin Biologic therapy (BRM, immunotherapy) bladder Yes
Afinitor Chemotherapy breast, Lung, other cancer Yes
Akeega Chemotherapy Prostate See Remarks
Albendazole AIDS drug No
Albuterol Sulfate Ancillary Agent No
Alectinib Chemotherapy Lung, Lymphoma Yes
Alemtuzumab Biologic therapy (BRM, immunotherapy) Leukemia, lymphoma Yes
Alendronate Sodium Ancillary Agent No
Alitretinoin Differentiation inducing agent Breast, Kaposi sarcoma, leukemia, sarcoma, skin cancer No
Allopurinol Ancillary Agent No
Allosteric ErbB Inhibitor BDTX-189 Chemotherapy Yes
Alpharadin Radiation Bone metastases Yes
Altretamine Chemotherapy Ovarian cancer Yes
Amifostine Ancillary Agent Breast, leukemia, lymphoma, NSCLC, prostate, skin cancer No
Aminocamptothecin Chemotherapy Leukemia, breast, lung cancer, lymphoma Yes
Aminoglutethimide Hormones and hormonal mechanisms Yes
Aminopterin Chemotherapy Leukemia Yes
Aminosyn Ancillary Agent No
Amtagvil Biologic therapy (BRM, immunotherapy) Yes
Anagrelide HCl Differentiation inducing agent Essential thrombocythemia Yes
Anastrozole Hormones and hormonal mechanisms Breast cancer Yes
Ancitabine Hydrochloride Chemotherapy Yes
Anktiva Biologic therapy (BRM, immunotherapy) Bladder Yes
Antithymocyte Globulin Biologic therapy (BRM, immunotherapy) No
Apaziquone Ancillary Agent, Chemotherapy Bladder cancer See Remarks
Aprepitant Ancillary Agent No
Asparaginase Chemotherapy Acute lymphoblastic leukemia (ALL) Yes
Asparaginase (Erwinia carotovora) Chemotherapy Yes
Name Primary Site
7+3
ABCD
ABCM
ABD
ABDIC
ABVD
AC Breast
AC-T
ACOAP
ACOPP
ACT-FU-Cy
ACVBP
AD
ADE
ADM
ADOC
AIM
ALOMAD
APO regimen
ASHAP
ASHAP/M-BACOS
ATRA (263)
Adria-L-PAM
B-DOPA
BAC
BACO
BACOD
BACON
BAMON
BAVIP
BBD
BBVP-M
BCAP
BCAVe
BCD
BCMF
BCP
BCVP
BCVPP-bleo
BEACOPP
BEMP
BEP Testicle
BIRD
BLEO-COMF
BOLD Colorectal, skin
BOMP
BONP
BOPAM
BOPP
BV
Glossary